PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis (vol 18, pg 3588, 2021)
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES(2022)